NeuroVasc Technologies Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$34M
- Investors
-
2
NeuroVasc Technologies General Information
Description
Developer of novel catheter-based technologies designed to treat neurovascular disease. The company offers a portfolio development strategy to bring differentiated tools to facilitate broad treatment options for patients suffering from a stroke and other neurovascular diseases, enabling physicians to treat patients suffering from an acute ischemic stroke.
Contact Information
Website
neurovasctechnologies.comCorporate Office
- 3 Jenner
- Suite 100
- Irvine, CA 92618
- United States
Corporate Office
- 3 Jenner
- Suite 100
- Irvine, CA 92618
- United States
NeuroVasc Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 27-Feb-2020 | $34M | Completed | Generating Revenue | ||
| 3. Secondary Transaction - Private | Completed | Startup | ||||
| 2. Early Stage VC (Series B) | 16-May-2018 | $6.3M | $9M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Nov-2015 | $2.7M | $2.7M | Completed | Startup |
NeuroVasc Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
NeuroVasc Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NeuroVasc Technologies Patents
NeuroVasc Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019234672-A1 | Flow protection device for ischemic stroke treatment | Active | 12-Mar-2018 | ||
| AU-2019234672-B2 | Flow protection device for ischemic stroke treatment | Inactive | 12-Mar-2018 | ||
| CA-3093697-A1 | Flow protection device for ischemic stroke treatment | Active | 12-Mar-2018 | ||
| CA-3093697-C | Flow protection device for ischemic stroke treatment | Active | 12-Mar-2018 | ||
| EP-3764926-A1 | Flow protection device for ischemic stroke treatment | Inactive | 12-Mar-2018 | A61F2/013 |
NeuroVasc Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NeuroVasc Technologies Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shandong Weigao Group Medical Polymer | Corporation | Minority | ||
| Liyuan Venture Capital | Venture Capital | Minority |
NeuroVasc Technologies FAQs
-
When was NeuroVasc Technologies founded?
NeuroVasc Technologies was founded in 2015.
-
Where is NeuroVasc Technologies headquartered?
NeuroVasc Technologies is headquartered in Irvine, CA.
-
What is the size of NeuroVasc Technologies?
NeuroVasc Technologies has 21 total employees.
-
What industry is NeuroVasc Technologies in?
NeuroVasc Technologies’s primary industry is Therapeutic Devices.
-
Is NeuroVasc Technologies a private or public company?
NeuroVasc Technologies is a Private company.
-
What is NeuroVasc Technologies’s current revenue?
The current revenue for NeuroVasc Technologies is .
-
How much funding has NeuroVasc Technologies raised over time?
NeuroVasc Technologies has raised $43M.
-
Who are NeuroVasc Technologies’s investors?
Shandong Weigao Group Medical Polymer and Liyuan Venture Capital have invested in NeuroVasc Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
